Related references
Note: Only part of the references are listed.Anti-inflammatory effects of tobramycin and a coppertobramycin complex with superoxide dismutase-like activity
M. Gziut et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Ozone Is Associated With an Increased Risk of Respiratory Exacerbations in Patients With Cystic Fibrosis
Sylvia C. L. Farhat et al.
CHEST (2013)
Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: The early intervention in cystic fibrosis exacerbation (eICE) trial
N. Lechtzin et al.
CONTEMPORARY CLINICAL TRIALS (2013)
Peroxidized unsaturated fatty acids stimulate Toll-like receptor 4 signaling in endothelial cells
Akiko Mutoh et al.
LIFE SCIENCES (2013)
A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care
Gregory S. Sawicki et al.
PEDIATRIC PULMONOLOGY (2013)
Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients
Rogier A. S. Hoek et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
Alex R. Horsley et al.
THORAX (2013)
Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa
Michael D. Parkins et al.
CHEST (2012)
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
Valerie Waters et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
The Adult Cystic Fibrosis Airway Microbiota Is Stable over Time and Infection Type, and Highly Resilient to Antibiotic Treatment of Exacerbations
Anthony A. Fodor et al.
PLOS ONE (2012)
Sputum Biomarkers and the Prediction of Clinical Outcomes in Patients with Cystic Fibrosis
Theodore G. Liou et al.
PLOS ONE (2012)
Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis
Iara Maria Sequeiros et al.
CHRONIC RESPIRATORY DISEASE (2012)
Extending the course of intravenous antibiotics in adult patients with cystic fibrosis with acute pulmonary exacerbations
Iara Maria Sequeiros et al.
CHRONIC RESPIRATORY DISEASE (2012)
Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
Kaissa de Boer et al.
THORAX (2011)
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Don B. Sanders et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis
R. H. LAWRENCE et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Increased lipid peroxidation and abnormal fatty acid profiles in seminal and blood plasma of normozoospermic males from infertile couples
I. Oborna et al.
HUMAN REPRODUCTION (2010)
Sputum and serum calprotectin are useful biomarkers during CF exacerbation
R. D. Gray et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Cystic Fibrosis Fatty Acid Imbalance Is Linked to Ceramide Deficiency and Corrected by Fenretinide
Claudine Guilbault et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Lipoxin A4 and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy
Raphael Chiron et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Cystic fibrosis pulmonary guidelines - Chronic medications for maintenance of lung health
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Fatty acids platelets and oxidative markers following intravenous n-3 fatty acids administration in cystic fibrosis: An open pilot observational study
Isabelle Durieu et al.
JOURNAL OF CYSTIC FIBROSIS (2007)
The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation
Damian G. Downey et al.
PEDIATRIC PULMONOLOGY (2007)
Plasma fatty acids and lipid hydroperoxides increase after antibiotic therapy in cystic fibrosis
I. Durieu et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid
Sinead M. Weldon et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2007)
Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study
JD Lloyd-Still et al.
NUTRITION (2006)
Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy
C Colombo et al.
PEDIATRIC PULMONOLOGY (2005)
Association of cystic fibrosis with abnormalities in fatty acid metabolism
SD Freedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Predictive 5-year survivorship model of cystic fibrosis
TG Liou et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation
SA McColley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs
JS Elborn et al.
THORAX (2000)
Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis
AL Quittner et al.
JOURNAL OF PEDIATRIC PSYCHOLOGY (2000)
Share Paper
